Delta3substituted quinoline or quinoxaline derivatives and their use as phosphatidylinositol 3-kinase ( PI3K) inhibitors

Details for Australian Patent Application No. 2008231385 (hide)

Owner Amgen Inc.

Inventors Shin, Youngsook; Seganish, Jennifer; Chen, Yi; Hao, Xiaolin; Cushing, Timothy D.; Rzasa, Robert M.; He, Xiao; Reichelt, Andreas; Zhang, Dawei

Agent Shelston IP

Pub. Number AU-B-2008231385

PCT Pub. Number WO2008/118455

Priority 60/919,571 23.03.07 US

Filing date 24 March 2008

Wipo publication date 2 October 2008

Acceptance publication date 2 February 2012

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

1 October 2009 PCT application entered the National Phase

  PCT publication WO2008/118455 Priority application(s): WO2008/118455

2 February 2012 Application Accepted

  Published as AU-B-2008231385

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008231393-Gene expression signature for classification of cancers

2008231384-Heterocyclic compounds and their use